In conclusion, our work identifies CNOT3 as an important post-transcriptional regulator of β-cell identity and function, and raises the possibility that alterations in CNOT3 expression and/or dysregulation of the CCR4–NOT complex contribute to β-cell failure in diabetes. This evidence concerns the gene CCR4 and diabetes mellitus.